The gene–cancer spQTL pairs showing strong validation in both datasets include TP53 missense mutations and CDH1 truncations in BRCA and TP53 truncations in CRC (Supplementary Fig. S1B). This evidence concerns the gene TP53 and colorectal carcinoma.